ID

34153

Descrizione

MIBG Scintigraphy and Strain Echocardiography in the Detection of Subclinical Cardiovascular Effects One Year After (Neo)Adjuvant Breast Cancer Treatment With Docetaxel, Doxorubicin and Cyclophosphamide (TAC): a Pilot Study; ODM derived from: https://clinicaltrials.gov/show/NCT01246856

collegamento

https://clinicaltrials.gov/show/NCT01246856

Keywords

  1. 14/01/19 14/01/19 -
Titolare del copyright

see on clinicaltrials.gov

Caricato su

14 gennaio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Breast Cancer NCT01246856

Eligibility Breast Cancer NCT01246856

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
female patients with breast cancer, ≥ 18 years old at the time of breast cancer diagnosis
Descrizione

ID.1

Tipo di dati

boolean

(neo)adjuvant treatment with docetaxel, doxorubicin and cyclophosphamide (tac) completed one year before inclusion
Descrizione

ID.2

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence of breast cancer recurrence or metastatic disease
Descrizione

ID.3

Tipo di dati

boolean

evidence of heart disease at the time of breast cancer diagnosis
Descrizione

ID.4

Tipo di dati

boolean

evidence of renal failure at the time of cardiac evaluation
Descrizione

ID.5

Tipo di dati

boolean

pregnant or lactating
Descrizione

ID.6

Tipo di dati

boolean

participation in a research protocol with ionizing radiation within one year before inclusion.
Descrizione

ID.7

Tipo di dati

boolean

evidence of diabetes mellitus or parkinson's disease
Descrizione

ID.8

Tipo di dati

boolean

evidence of an mibg-accumulating tumor (pheochromocytoma, paraganglioma, chemodectoma, ganglioneuroma, neuroblastoma, carcinoid, medullary thyroid cancer, neurofibromatosis, retinoblastoma, esthesioneuroma, schwannoma, merkelcel-tumor, pancreatic islet cell tumors, small cell lung carcinoma, melanoma
Descrizione

ID.9

Tipo di dati

boolean

Similar models

Eligibility Breast Cancer NCT01246856

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
female patients with breast cancer, ≥ 18 years old at the time of breast cancer diagnosis
boolean
ID.2
Item
(neo)adjuvant treatment with docetaxel, doxorubicin and cyclophosphamide (tac) completed one year before inclusion
boolean
Item Group
C0680251 (UMLS CUI)
ID.3
Item
evidence of breast cancer recurrence or metastatic disease
boolean
ID.4
Item
evidence of heart disease at the time of breast cancer diagnosis
boolean
ID.5
Item
evidence of renal failure at the time of cardiac evaluation
boolean
ID.6
Item
pregnant or lactating
boolean
ID.7
Item
participation in a research protocol with ionizing radiation within one year before inclusion.
boolean
ID.8
Item
evidence of diabetes mellitus or parkinson's disease
boolean
ID.9
Item
evidence of an mibg-accumulating tumor (pheochromocytoma, paraganglioma, chemodectoma, ganglioneuroma, neuroblastoma, carcinoid, medullary thyroid cancer, neurofibromatosis, retinoblastoma, esthesioneuroma, schwannoma, merkelcel-tumor, pancreatic islet cell tumors, small cell lung carcinoma, melanoma
boolean

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial